scPharmaceuticals Inc. (SCPH) Tops Q2 EPS by 1c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q2 EPS of ($0.36), $0.01 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.64 million versus the consensus estimate of $1.45 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target
• American Eagle Outfitters (AEO) PT Lowered to $27 at UBS, Buy Rating Maintained
• Bernstein SocGen on Cintas (CTAS): 'Setting up for a margin and EPS beat'